Literature DB >> 26405541

Realgar quantum dots induce apoptosis and necrosis in HepG2 cells through endoplasmic reticulum stress.

Y U Qin1, Huan Wang2, Zheng-Yun Liu1, Jie Liu1, Jin-Zhu Wu3.   

Abstract

Realgar (As4S4) has been used in traditional Chinese medicines for treatment of malignancies. However, the poor water solubility of realgar limits its clinical application. To overcome this problem, realgar quantum dots (RQDs; 5.48±1.09 nm) were prepared by a photoluminescence method. The mean particle size was characterized by high-resolution transmission electron microscopy and scanning electron microscopy. Our recent studies revealed that the RQDs were effective against tumor growth in tumor-bearing mice without producing apparent toxicity. The present study investigated their anticancer effects and mechanisms in human hepatocellular carcinoma (HepG2) cells. The HepG2 cells and human normal liver (L02) cells were used to determine the cytotoxicity of RQDs. The portion of apoptotic and dead cells were measured by flow cytometry with Annexin V-fluorescein isothiocyanate/propidium iodide double staining. Apoptosis-related proteins and genes were examined by western blot analysis and reverse transcription-quantitative polymerase chain reaction, and the mitochondrial membrane potential was assayed by confocal microscope with JC-1 as a probe. RQDs exhibited cytotoxicity in a concentration-dependent manner and HepG2 cells were more sensitive compared with normal L02 cells. At 15 µg/ml, 20% of the cells were apoptotic, while 60% of the cells were necrotic at 30 µg/ml. The anti-apoptosis protein Bcl-2 was dose-dependently decreased, while pro-apoptotic protein Bax was increased. There was a loss of mitochondrial membrane potential and expression of the stress genes C/EBP-homologous protein 10 and glucose-regulated protein 78 was increased by RQDs. RQDs were effective in the inhibition of HepG2 cell proliferation and this effect was due to induction of apoptosis and necrosis through endoplasmic reticulum stress.

Entities:  

Keywords:  Bax/Bcl-2; HepG2 cells; apoptosis; endoplasmic reticulum stress; necrosis; realgar quantum dots

Year:  2015        PMID: 26405541      PMCID: PMC4534832          DOI: 10.3892/br.2015.489

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  22 in total

1.  Anti-tumor effects and apoptosis induction by Realgar bioleaching solution in Sarcoma-180 cells in vitro and transplanted tumors in mice in vivo.

Authors:  Qin-Jian Xie; Xin-Li Cao; Lu Bai; Zheng-Rong Wu; Ying-Ping Ma; Hong-Yu Li
Journal:  Asian Pac J Cancer Prev       Date:  2014

2.  Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.

Authors:  Hong-Hu Zhu; De-Pei Wu; Jie Jin; Jian-Yong Li; Jun Ma; Jian-Xiang Wang; Hao Jiang; Sai-Juan Chen; Xiao-Jun Huang
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

Review 3.  Targeting ER stress induced apoptosis and inflammation in cancer.

Authors:  Tom Verfaillie; Abhishek D Garg; Patrizia Agostinis
Journal:  Cancer Lett       Date:  2010-08-21       Impact factor: 8.679

4.  As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia.

Authors:  Jian-Hua Mao; Xiao-Yan Sun; Jian-Xiang Liu; Qun-Ye Zhang; Ping Liu; Qiu-Hua Huang; Keqin Kathy Li; Quan Chen; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

5.  Oxidative stress is involved in Patulin induced apoptosis in HEK293 cells.

Authors:  Baigang Zhang; Xiaoli Peng; Guanghui Li; Yunfeng Xu; Xiaodong Xia; Qian Wang
Journal:  Toxicon       Date:  2014-12-03       Impact factor: 3.033

6.  Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC‑1.

Authors:  Xinyu Liu; Xianglu Li; Ling Wang; Xiao Lv; Na Chen; Peipei Li; Kang Lu; Xin Wang
Journal:  Mol Med Rep       Date:  2013-10-14       Impact factor: 2.952

Review 7.  In the war against solid tumors arsenic trioxide needs partners.

Authors:  Pochi R Subbarayan; Bach Ardalan
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 8.  Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).

Authors:  Peter Baláž; Ján Sedlák
Journal:  Toxins (Basel)       Date:  2010-06-21       Impact factor: 4.546

9.  Arsenic sulfide as a potential anti‑cancer drug.

Authors:  Wenping Ding; Lian Zhang; Sungkyoung Kim; Wei Tian; Yingying Tong; Jianwen Liu; Yong Ma; Siyu Chen
Journal:  Mol Med Rep       Date:  2014-11-03       Impact factor: 2.952

10.  Enhanced antitumor activity of realgar mediated by milling it to nanosize.

Authors:  Ye Tian; Xiaobo Wang; Ronggang Xi; Weisan Pan; Shuang Jiang; Zhao Li; Yu Zhao; Guanghui Gao; Dan Liu
Journal:  Int J Nanomedicine       Date:  2014-01-31
View more
  6 in total

1.  Acid Water-ground Nano-realgar Is Superior to Crude Realgar in Promoting Apoptosis of MCF-7 Breast Cancer Cells.

Authors:  Juan Xi; Jia-Hui Fang; Xiao-Mei Xiong; Chun Gui; Yu-Xue Wang; Xiu-Qiao Zhang
Journal:  Curr Med Sci       Date:  2022-07-05

2.  Role of nuclear factor (erythroid-derived 2)-like 2 in the age-resistant properties of the glaucoma trabecular meshwork.

Authors:  Jintao Cheng; Jiamei Liang; Jinze Qi
Journal:  Exp Ther Med       Date:  2017-06-02       Impact factor: 2.447

Review 3.  Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles.

Authors:  Reza Mohammadinejad; Mohammad Amin Moosavi; Shima Tavakol; Deniz Özkan Vardar; Asieh Hosseini; Marveh Rahmati; Luciana Dini; Salik Hussain; Ali Mandegary; Daniel J Klionsky
Journal:  Autophagy       Date:  2018-09-13       Impact factor: 16.016

4.  Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.

Authors:  Dan Shi; Yan Liu; Ronggang Xi; Wei Zou; Lijun Wu; Zhiran Zhang; Zhongyang Liu; Chao Qu; Baoli Xu; Xiaobo Wang
Journal:  Int J Nanomedicine       Date:  2016-11-07

5.  Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells.

Authors:  Yuxue Zhao; Kenji Onda; Kentaro Sugiyama; Bo Yuan; Sachiko Tanaka; Norio Takagi; Toshihiko Hirano
Journal:  Oncol Rep       Date:  2018-10-09       Impact factor: 3.906

Review 6.  Mineral medicine: from traditional drugs to multifunctional delivery systems.

Authors:  Xiaoqing Zhong; Zhenning Di; Yuanxin Xu; Qifan Liang; Kuanhan Feng; Yuting Zhang; Liuqing Di; Ruoning Wang
Journal:  Chin Med       Date:  2022-02-10       Impact factor: 5.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.